{"id":545273,"date":"2026-02-05T00:00:00","date_gmt":"2025-10-03T15:35:44","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/"},"modified":"2026-03-12T23:42:26","modified_gmt":"2026-03-13T03:42:26","slug":"understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/","title":{"rendered":"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant"},"content":{"rendered":"

With the recent authorization of fezolinetant and elinzanetant for VMS by Health Canada, it is important that clinicians understand the associated monitoring requirements. This module focuses on the specific safety monitoring guidelines set out by Health Canada for these therapies to ensure safe patient management.\u00a0<\/p>","protected":false},"featured_media":547608,"comment_status":"closed","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-545273","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nUnderstanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"With the recent authorization of fezolinetant and elinzanetant for VMS by Health Canada, it is important that clinicians understand the associated monitoring requirements. This module focuses on the specific safety monitoring guidelines set out by Health Canada for these therapies to ensure safe patient management.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-13T03:42:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/\",\"name\":\"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg\",\"datePublished\":\"2025-10-03T15:35:44+00:00\",\"dateModified\":\"2026-03-13T03:42:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/","og_locale":"fr_CA","og_type":"article","og_title":"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase","og_description":"With the recent authorization of fezolinetant and elinzanetant for VMS by Health Canada, it is important that clinicians understand the associated monitoring requirements. This module focuses on the specific safety monitoring guidelines set out by Health Canada for these therapies to ensure safe patient management.\u00a0","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/","og_site_name":"MDBriefCase","article_modified_time":"2026-03-13T03:42:26+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/","url":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/","name":"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg","datePublished":"2025-10-03T15:35:44+00:00","dateModified":"2026-03-13T03:42:26+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2026\/02\/VMS7_LP_2162135319-4.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/understanding-monitoring-requirements-for-fezolinetant-and-elinzanetant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Understanding Monitoring Requirements for Fezolinetant and Elinzanetant"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/545273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=545273"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/545273\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/547608"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=545273"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=545273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}